Allan I Levey Selected Research

VU0364572

10/2016

Effects of Selective M1 Muscarinic Receptor Activation on Hippocampal Spatial Representations and Neuronal Oscillations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allan I Levey Research Topics

Disease

92	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 06/2003
24	Cognitive Dysfunction 01/2022 - 02/2006
21	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2004
14	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2003
10	Dementia (Dementias) 01/2022 - 01/2004
9	Neuroinflammatory Diseases 07/2022 - 01/2017
9	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2013 - 11/2009
8	Inflammation (Inflammations) 01/2022 - 10/2009
7	Disease Progression 01/2020 - 12/2010
7	Amyloid Plaque 11/2013 - 08/2004
6	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 03/2010
5	Tauopathies 01/2022 - 10/2009
3	Hippocampal Sclerosis 06/2022 - 11/2020
3	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 06/2022 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2016 - 08/2012
3	Neuroblastoma 03/2014 - 10/2002
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2012 - 03/2005
2	Proteostasis Deficiencies 07/2022 - 01/2022
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2022 - 01/2022
2	Atherosclerosis 01/2022 - 08/2012
2	Infarction (Infarctions) 01/2022 - 11/2020
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 08/2012
2	Vascular Diseases (Vascular Disease) 01/2022 - 08/2012
2	limbic-predominant age-related TDP-43 encephalopathy 01/2022 - 01/2019
2	Corticobasal Degeneration 11/2013 - 08/2012
2	TDP-43 Proteinopathies 01/2012 - 04/2010
2	Seizures (Absence Seizure) 03/2003 - 07/2002
1	Parkinsonian Disorders (Parkinsonism) 05/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Amyloidosis 01/2022
1	Synucleinopathies 01/2022
1	Arteriolosclerosis 01/2022

Drug/Important Bio-Agent (IBA)

56	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2002
17	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2005
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2004
15	ProteomeIBA 01/2022 - 08/2004
10	Amyloid beta-PeptidesIBA 07/2022 - 02/2006
9	Apolipoproteins E (ApoE)IBA 06/2022 - 09/2009
9	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 03/2010
7	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2012
7	LipidsIBA 01/2021 - 01/2008
7	ApolipoproteinsIBA 01/2019 - 08/2004
7	UbiquitinIBA 10/2018 - 03/2004
6	Detergents (Detergent)IBA 01/2021 - 11/2009
5	CholesterolIBA 07/2022 - 01/2008
5	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2012
5	Peptides (Polypeptides)IBA 01/2020 - 12/2010
5	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2017 - 07/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
4	Protein AggregatesIBA 10/2018 - 11/2009
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2016 - 09/2002
3	LDL CholesterolIBA 06/2022 - 01/2016
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 01/2013
3	Biological ProductsIBA 01/2021 - 02/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 12/2010
3	U1 Small Nuclear RibonucleoproteinIBA 01/2018 - 04/2014
3	Cholinergic Agents (Cholinergics)IBA 10/2016 - 06/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	Methylphenidate (Ritalin)FDA LinkGeneric 11/2021 - 01/2021
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2021 - 07/2002
2	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2017
2	IsotopesIBA 01/2019 - 05/2012
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 02/2015
2	Cholinergic Antagonists (Anticholinergics)IBA 09/2017 - 08/2003
2	sarkosylIBA 12/2016 - 12/2014
2	Donepezil (Aricept)FDA LinkGeneric 10/2016 - 01/2004
2	HDL CholesterolIBA 06/2016 - 01/2016
2	asparaginylendopeptidase (legumain)IBA 11/2015 - 11/2014
2	Threonine (L-Threonine)FDA Link 02/2015 - 11/2013
2	Small Nuclear Ribonucleoproteins (snRNP)IBA 12/2014 - 04/2014
2	Dichlorodiphenyl Dichloroethylene (DDE)IBA 08/2014 - 03/2014
2	PesticidesIBA 03/2014 - 10/2011
2	Nuclear Proteins (Protein, Nuclear)IBA 07/2013 - 08/2012
2	SynucleinsIBA 06/2013 - 04/2012
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2012 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 12/2010
2	PolyubiquitinIBA 03/2011 - 04/2010
2	LDL Receptors (LDL Receptor)IBA 02/2011 - 08/2004
2	LigandsIBA 08/2010 - 05/2010
2	EnzymesIBA 05/2008 - 03/2005
2	Protein Deglycase DJ-1IBA 01/2007 - 02/2004
2	thioflavin TIBA 01/2006 - 08/2004
2	Pilocarpine (Ocusert)FDA LinkGeneric 03/2003 - 07/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022
1	SilverIBA 06/2022
1	oxidized low density lipoproteinIBA 06/2022
1	CalciumIBA 01/2022
1	AutoantigensIBA 01/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	OsteoprotegerinIBA 01/2022
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2022
1	CytokinesIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Mitogen-Activated Protein KinasesIBA 06/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	OxylipinsIBA 01/2021

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2004
3	Lasers (Laser) 01/2011 - 08/2004